Durvalumab,Monalizumab,Oleclumab,Ceralasertib,DOCETAXEL,Savolitinib
AstraZeneca,Innate,Sanofi,Aventis,hutchmed
['biomarker', 'nsclc', 'sclc', 'pioneer']
attending #esmoimmuno22?
don't miss the presentation on the #pioneerproject with today at 14:45 "comprehensive #biomarkers analysis to predict efficacy of #pd1l1 #icis in combination with #chemotherapy: a subgroup analysis of the pioneer trial"
#nsclc #precisiononcology 
The French #ImmunologyCluster #CrossInnovation in #ImmunoOncology and #InflammatoryDiseases #Immunotherapy #MonoclonalAntibody #InnateImmunity #Immunoscore...